LL-37 5mg – Antimicrobial Peptide for Immune Modulation and Infection Research
Overview and Scientific Background
LL-37 5mg is a research-grade formulation of a naturally occurring human antimicrobial peptide belonging to the cathelicidin family. It is derived from the precursor protein hCAP18 and plays a key role in the innate immune system.
In research settings, LL-37 is widely studied for its potential involvement in antimicrobial defense, immune system regulation, inflammation control, and tissue repair signaling. It is one of the few human-derived peptides known to have both antimicrobial and immunomodulatory properties.
Real-World Research and Experimental Findings
Most scientific evidence for LL-37 comes from in vitro studies and preclinical research, where it has demonstrated broad biological activity against bacteria, viruses, and fungi.
Key experimental findings include:
- Broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria
- Potential antiviral effects in laboratory models
- Modulation of innate immune responses through immune cell signaling
- Regulation of inflammatory cytokines in tissue environments
- Possible role in wound healing and epithelial repair mechanisms
Research also suggests LL-37 may help maintain barrier integrity in skin, respiratory, and gastrointestinal tissues.
Mechanism of Action
LL-37 works through multiple biological pathways associated with innate immunity:
- Membrane disruption: Directly interacts with microbial membranes, leading to structural breakdown
- Immune signaling modulation: Influences macrophages, neutrophils, and dendritic cell activity
- Inflammation regulation: Balances pro- and anti-inflammatory cytokine production
- Tissue repair signaling: Supports epithelial regeneration in injury models
- Endotoxin neutralization: Binds to bacterial endotoxins such as LPS
This multifunctional activity makes it a key subject in immunology and infectious disease research.
Pharmacokinetics and Biological Activity
LL-37 is a short peptide that is rapidly metabolized in biological systems, which is why research focuses heavily on its local tissue effects rather than long systemic circulation.
Observed experimental trends include:
- Rapid antimicrobial action in localized environments
- Immune cell activation and modulation
- Reduction of inflammatory signaling in controlled models
- Support of epithelial barrier repair in wound studies
Why LL-37 5mg Is Used in Research
LL-37 5mg is commonly used in laboratory research to evaluate innate immune mechanisms and antimicrobial pathways. It is particularly studied for:
- Host defense against microbial infection models
- Immune system signaling regulation
- Inflammation control in tissue environments
- Wound healing and epithelial regeneration research
It is considered an important peptide in immunology and infectious disease research frameworks.
Usage Guidance
LL-37 5mg is intended strictly for controlled laboratory and scientific research use. All experimental design, handling, and administration must be conducted by qualified researchers in appropriate research environments.
FAQs
1. What is LL-37 used for in research?
It is studied for antimicrobial activity, immune regulation, and inflammation control.
2. Is LL-37 naturally occurring?
Yes, it is a naturally occurring human antimicrobial peptide.
3. What organisms does it act against?
It has shown activity against bacteria, viruses, and fungi in lab studies.
4. How does LL-37 work?
It disrupts microbial membranes and modulates immune system signaling.
5. Does it affect inflammation?
Yes, it helps regulate cytokine activity in immune responses.
6. Is there human clinical use?
It is not an approved therapeutic drug; research is still ongoing.
7. What tissues is it studied in?
Skin, respiratory tract, gastrointestinal lining, and immune tissues.
8. Why is the 5mg dose used?
It is commonly used in laboratory research for controlled experimental studies.
9. Does it support wound healing?
Preclinical studies suggest involvement in epithelial repair processes.
10. Is LL-37 an antibiotic?
No, it is a naturally occurring antimicrobial peptide, not a pharmaceutical antibiotic.
Disclaimer
All products listed are intended strictly for research purposes only. They are not approved for human consumption, medical use, or therapeutic application. Use must comply with all applicable laws and regulations.
